Horiuchi Daisuke | Department Of Cardiology Hirosaki University Graduate School Of Medicine

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Long-term Efficacy of Combination Therapy with Anti-arrhythmic Agents and Pravastatin in Patients with Paroxysmal Atrial Fibrillation
Efficacy of Long-term Flecainide Therapy in Patients with Paroxysmal Atrial Fibrillation : Analysis Based on Time of Onset
OE-242 Amiodarone Attenuates the Upregulated Matrix Metalloprotease-2 Activity in a Rat Myocardial Infarction Model(Chronic coronary heart disease/Remodeling(01)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulatio
Amiodarone Attenuates the Upregulated Matrix Metalloproteinase-2 Activity in a Rat Myocardial Infarction Model
PJ-443 Inhibitory Effect of Low Dose Pioglitazone on the In-stent Restenosis in Patients with Acute Myocardial Infarction and Type 2 Diabetes(Acute myocardial infarction, clinical (diagnosis/treatment)-9 (IHD) PJ75,Poster Session (Japanese),The 70th Anniv
OE-283 Electrocardiographic characteristics in differentiating the mechanism and the origin of atrial tachycardia(ECG/Body surface potential mapping/Holter(01)(A),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation So
PJ-211 Amiodarone is Safe and Highly Effective Therapy for Supraventricular Tachycardia in Patient with Acute Heart Failure(Arrhythmia, therapy-18, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
PJ-603 Enhanced Asymmetric Dimethylarginine Synthesis in the Atrium of a Canine Atrial Fibrillation Model : A Possible Role in Endocardial Remodeling(Arrhythmia, basic-5 (A) PJ101,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of
PJ-208 Left Ventricular Dyssynchrony by Tissue Doppler Echocardiography as a Predictor of Prognosis after Cardiac Resynchronization Therapy for Advanced Heart Failure(Heart failure, clinical-15 (M) PJ35,Poster Session (Japanese),The 70th Anniversary Annua
OJ-354 Sinus Venosa Region as an Anatomical and Not Functional Obstacle in Isthmus-dependent Atrial Flutter(Arrhythmia, diagnosis/pathophysiology/EPS-4 (A) OJ59,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Ci
Randomized Crossover Study of the Long-Term Effects of Pilsicainide and Cibenzoline in Preventing Recurrence of Symptomatic Paroxysmal Atrial Fibrillation : Influence of the Duration of Arrhythmia Before Therapy(Clinical Investigation)
OJ-062 Elevated Plasma Level of Asymmetrical Dimethylarginine in Patients with Atrial Fibrillation : Possible Role for Cardiovascular Events(Arrhythmia, diagnosis/pathophysiology/EPS-3 (A) OJ11,Oral Presentation (Japanese),The 70th Anniversary Annual Scie
PJ-653 The Relationship between Long-term Preventive Effect of Antiarrhythmic Drug Therapy and Symptomatic Thromboembolism in Patients with Lone Paroxysmal Atrial Fibrillation(Cerebrovascular circulation/Stroke-3 (H) PJ110,Poster Session (Japanese),The 70
PJ-312 Different Efficacy of Combination Therapy with Antiarrhythmic Drugs and Enalapril between the Patients Groups with and without Underlying Heart Disease(Arrhythmia, therapy-14 (A) PJ53,Poster Session (Japanese),The 70th Anniversary Annual Scientific
PE-021 The Combination Therapy with Antiarrhythmic Drugs and Pravastatin in Patients with Lone Atrial Fibrillation Prevents the Development of Structural Remodeling(Arrhythmia, diagnosis/pathophysiology/EPS-6 (A) PE4,Poster Session (English),The 70th Anni
OJ-118 Long-term Prognosis of Antithrombotic Therapy According to Guideline Recommended by Japanese Circulation Society in Patients with non-valvular Paroxysmal Atrial Fibrillation(Thromboembolism/Antithrombotic therapy/Thrombolysis-2 (H) OJ20,Oral Presen
Angiotensin Converting Enzyme Inhibitor Enhances Efficacy of Amiodarone and not Class-I Antiarrhythmic Drug in Preventing Recurrence of Paroxysmal Atrial Fibrillation(Arrhythmia, Pharmacological Therapy 2 (A), The 69th Annual Scientific Meeting of the Jap
Relationship between the Response to Antiarrhythmic Drug Therapy and the Development of Structural Remodeling in Patients with Paroxysmal Atrial Fibrillation(Arrhythmia, Diagnosis/Pathophysiology/EPS 3 (A), The 69th Annual Scientific Meeting of the Japane
Pravastatin Enhances the Efficacy of Class I Antiarrhythmic Agents in Patients with Paroxysmal Atrial Fibrillation and Hyperlipidemia(Arrhythmia, Non-pharmacological Therapy 8 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Efficacy of Antiarrhythmic Therapy in Preventing Recurrence of Paroxysmal Atrial Fibrillation not Showing Any Circadian Variation in the Onset(Arrhythmia, Pharmacological Therapy 1 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Societ
Long-Term Prognosis of Patients With Paroxysmal Atrial Fibrillation Depends on Their Response to Antiarrhythmic Therapy
PJ-197 Characteristics of patients with paroxysmal atrial fibrillation and diabetes mellitus and long-term preventive efficacy of antiarrhythmic agents(Arrhythmia, Pharmacological Therapy 2 (A) : PJ33)(Poster Session (Japanese))
PE-111 A randomized crossover study on the long-term efficacy of pilsicainide and cibenzoline in preventing recurrence of paroxysmal atrial fibrillation(Arrhythmia, Pharmacological Therapy 1 (A) : PE19)(Poster Session (English))
PE-108 The long-term preventive effect of amiodarone in patients with paroxysmal and persistent atrial fibrillation; Analysis based on patients characteristics(Arrhythmia, Pharmacological Therapy 1 (A) : PE19)(Poster Session (English))
OJ-375 The relationship between the long-term preventive effect of antiarrhythmic agents and symptomatic thromboembolism in patients with paroxysmal atrial fibrillation(Thromboembolism/Thrombolysis 3 (IHD) : OJ45)(Oral Presentation (Japanese))
OE-336 The relationship between the duration of arrhythmia and subsequent preventive effect of amiodarone in patients with paroxysmal/persistent atrial fibrillation(Arrhythmia, Pharmacological Therapy 4 (A): OE42)(Oral Presentation (English))
The Long-Term Efficacy of Amiodarone in Patients with Paroxysmal Atrial Fibrillation : Comparison of Groups between with and without Heart Failure
Angiotensin Converting Enzyme Inhibitor Enhances the Efficacy of Antiarrhythmic Agents in Patients with Paroxysmal Atrial Fibrillation and Essential Hypertension
Time in the Therapeutic Range During Warfarin Therapy in Japanese Patients With Non-Valvular Atrial Fibrillation : A Multicenter Study of Its Status and Influential Factors

もっと見る

スポンサーリンク